These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 20140016)
1. Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma. Wang J; Kim J; Roh M; Franco OE; Hayward SW; Wills ML; Abdulkadir SA Oncogene; 2010 Apr; 29(17):2477-87. PubMed ID: 20140016 [TBL] [Abstract][Full Text] [Related]
2. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity. Kim J; Roh M; Abdulkadir SA BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470 [TBL] [Abstract][Full Text] [Related]
3. Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells. Wang J; Anderson PD; Luo W; Gius D; Roh M; Abdulkadir SA Oncogene; 2012 Apr; 31(14):1794-803. PubMed ID: 21860423 [TBL] [Abstract][Full Text] [Related]
4. Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress. Zhang C; Qie Y; Yang T; Wang L; Du E; Liu Y; Xu Y; Qiao B; Zhang Z Carcinogenesis; 2019 Mar; 40(1):52-60. PubMed ID: 30247545 [TBL] [Abstract][Full Text] [Related]
5. PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer. Kirschner AN; Wang J; van der Meer R; Anderson PD; Franco-Coronel OE; Kushner MH; Everett JH; Hameed O; Keeton EK; Ahdesmaki M; Grosskurth SE; Huszar D; Abdulkadir SA J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505253 [TBL] [Abstract][Full Text] [Related]
6. PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance. Holder SL; Abdulkadir SA Curr Cancer Drug Targets; 2014; 14(2):105-14. PubMed ID: 24274399 [TBL] [Abstract][Full Text] [Related]
7. Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion. Ledet RJ; Ruff SE; Wang Y; Nayak S; Schneider JA; Ueberheide B; Logan SK; Garabedian MJ Commun Biol; 2021 Jan; 4(1):36. PubMed ID: 33398037 [TBL] [Abstract][Full Text] [Related]
8. Pim1 regulates androgen-dependent survival signaling in prostate cancer cells. van der Poel HG; Zevenhoven J; Bergman AM Urol Int; 2010; 84(2):212-20. PubMed ID: 20215828 [TBL] [Abstract][Full Text] [Related]
9. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Zippo A; De Robertis A; Serafini R; Oliviero S Nat Cell Biol; 2007 Aug; 9(8):932-44. PubMed ID: 17643117 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion. Eerola SK; Santio NM; Rinne S; Kouvonen P; Corthals GL; Scaravilli M; Scala G; Serra A; Greco D; Ruusuvuori P; Latonen L; Rainio EM; Visakorpi T; Koskinen PJ Cell Commun Signal; 2019 Nov; 17(1):148. PubMed ID: 31730483 [TBL] [Abstract][Full Text] [Related]
11. Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia. Narlik-Grassow M; Blanco-Aparicio C; Cecilia Y; Perez M; Muñoz-Galvan S; Cañamero M; Renner O; Carnero A PLoS One; 2013; 8(4):e60277. PubMed ID: 23565217 [TBL] [Abstract][Full Text] [Related]
12. PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis. Zhao B; Liu L; Mao J; Zhang Z; Wang Q; Li Q Cell Death Dis; 2018 Feb; 9(3):307. PubMed ID: 29472550 [TBL] [Abstract][Full Text] [Related]
13. Pim1 and Myc reversibly transform murine precursor B lymphocytes but not mature B lymphocytes. Bouquet C; Melchers F Eur J Immunol; 2012 Feb; 42(2):522-32. PubMed ID: 22101984 [TBL] [Abstract][Full Text] [Related]
14. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase. Zemskova MY; Song JH; Cen B; Cerda-Infante J; Montecinos VP; Kraft AS Cell Signal; 2015 Jan; 27(1):135-46. PubMed ID: 25451079 [TBL] [Abstract][Full Text] [Related]
15. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype. Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962 [TBL] [Abstract][Full Text] [Related]
16. Transgenic mice for Cre-inducible overexpression of the oncogenes c-MYC and Pim-1 in multiple tissues. Roh M; Kim J; Song C; Wills M; Abdulkadir SA Genesis; 2006 Oct; 44(10):447-53. PubMed ID: 17013838 [TBL] [Abstract][Full Text] [Related]
17. N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells. Lee JK; Phillips JW; Smith BA; Park JW; Stoyanova T; McCaffrey EF; Baertsch R; Sokolov A; Meyerowitz JG; Mathis C; Cheng D; Stuart JM; Shokat KM; Gustafson WC; Huang J; Witte ON Cancer Cell; 2016 Apr; 29(4):536-547. PubMed ID: 27050099 [TBL] [Abstract][Full Text] [Related]
18. The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells. Zemskova M; Sahakian E; Bashkirova S; Lilly M J Biol Chem; 2008 Jul; 283(30):20635-44. PubMed ID: 18426800 [TBL] [Abstract][Full Text] [Related]
19. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation. Gao X; Liu X; Lu Y; Wang Y; Cao W; Liu X; Hu H; Wang H Breast Cancer; 2019 Sep; 26(5):663-671. PubMed ID: 30989585 [TBL] [Abstract][Full Text] [Related]